AdvancedAdvT (ADVT) Competitors GBX 204.90 -5.10 (-2.43%) As of 11:36 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ADVT vs. CLIN, EVR, BGSC, GROW, PRSR, PINE, DX, ARR, SOHO, and SAGAShould you be buying AdvancedAdvT stock or one of its competitors? The main competitors of AdvancedAdvT include Clinigen Group (CLIN), EVRAZ (EVR), BMO Global Smaller Companies (BGSC), Molten Ventures (GROW), Prs Reit (PRSR), Pinewood Technologies Group (PINE), DX (Group) (DX), Aurora Investment Trust (ARR), Triple Point Social Housing REIT (SOHO), and Saga (SAGA). These companies are all part of the "trading" industry. AdvancedAdvT vs. Its Competitors Clinigen Group EVRAZ BMO Global Smaller Companies Molten Ventures Prs Reit Pinewood Technologies Group DX (Group) Aurora Investment Trust Triple Point Social Housing REIT Saga AdvancedAdvT (LON:ADVT) and Clinigen Group (LON:CLIN) are both small-cap trading companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Which has higher valuation & earnings, ADVT or CLIN? AdvancedAdvT has higher earnings, but lower revenue than Clinigen Group. Clinigen Group is trading at a lower price-to-earnings ratio than AdvancedAdvT, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdvancedAdvTN/AN/A£1.71M£0.90227.22Clinigen Group£565.60M0.00N/A£14.30N/A Do insiders and institutionals have more ownership in ADVT or CLIN? 66.5% of AdvancedAdvT shares are owned by institutional investors. 13.2% of AdvancedAdvT shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer ADVT or CLIN? In the previous week, AdvancedAdvT had 2 more articles in the media than Clinigen Group. MarketBeat recorded 2 mentions for AdvancedAdvT and 0 mentions for Clinigen Group. AdvancedAdvT's average media sentiment score of 0.32 beat Clinigen Group's score of 0.00 indicating that AdvancedAdvT is being referred to more favorably in the media. Company Overall Sentiment AdvancedAdvT Neutral Clinigen Group Neutral Is ADVT or CLIN more profitable? AdvancedAdvT has a net margin of 30.56% compared to Clinigen Group's net margin of 0.00%. AdvancedAdvT's return on equity of 1.17% beat Clinigen Group's return on equity.Company Net Margins Return on Equity Return on Assets AdvancedAdvT30.56% 1.17% 0.04% Clinigen Group N/A N/A N/A SummaryAdvancedAdvT beats Clinigen Group on 8 of the 10 factors compared between the two stocks. Get AdvancedAdvT News Delivered to You Automatically Sign up to receive the latest news and ratings for ADVT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADVT vs. The Competition Export to ExcelMetricAdvancedAdvTShell Companies IndustryFinancial SectorLON ExchangeMarket Cap£325.38M£493.62M£6.42B£3.09BDividend YieldN/A5.35%4.18%5.04%P/E Ratio227.220.8414.23174.56Price / SalesN/A733.181,861.16282,771.09Price / Cash0.98178.73127.1427.94Price / Book2.2266.315.215.38Net Income£1.71M-£141.08M£1.23B£5.89B7 Day Performance-3.94%-0.03%0.95%-0.04%1 Month Performance12.83%2.21%2.50%0.72%1 Year Performance53.48%61.66%28.55%64.34% AdvancedAdvT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADVTAdvancedAdvTN/AGBX 204.90-2.4%N/A+57.5%£325.38MN/A227.22209News CoverageCLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000EVREVRAZ0.521 of 5 starsGBX 81flatN/AN/A£1.18B£15.40B42.1971,591BGSCBMO Global Smaller CompaniesN/AN/AN/AN/A£769.56M£303.85M2.77N/AGROWMolten Ventures1.8058 of 5 starsGBX 371.42+0.5%GBX 580+56.2%-3.9%£691.23M£9.10M-20.7720Gap DownPRSRPrs ReitN/AGBX 104-0.4%GBX 120+15.4%+17.8%£569.20M£58.11M6.082PINEPinewood Technologies Group3.0392 of 5 starsGBX 518flatGBX 590+13.9%+52.1%£431.14M£26.97M9.475,334DXDX (Group)N/AN/AN/AN/A£306.77M£471.20M1,185.0020ARRAurora Investment TrustN/AGBX 251-0.4%N/A-5.6%£283.95M£55.59M5.57N/ASOHOTriple Point Social Housing REITN/AGBX 67.90+0.6%N/A+11.3%£270.79M£41.36M10.5510SAGASagaN/AGBX 188flatN/A+83.6%£261.28M£799.48M-1.763,682Trending News Related Companies and Tools Related Companies Clinigen Group Competitors EVRAZ Competitors BMO Global Smaller Companies Competitors Molten Ventures Competitors Prs Reit Competitors Pinewood Technologies Group Competitors DX (Group) Competitors Aurora Investment Trust Competitors Triple Point Social Housing REIT Competitors Saga Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:ADVT) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvancedAdvT Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvancedAdvT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access